All the news Showing 7 of 7 articles from: HBV vaccinationGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Trivalent hepatitis B vaccine appears more effective than existing options Liz Highleyman / 18 October 2019 Sci-B-Vac, an investigational vaccine that contains three different hepatitis B virus (HBV) proteins, may offer more protection, especially for older adults, than widely used existing vaccine options, according to late-breaking study results presented ... Lancet commission sets agenda for the elimination of viral hepatitis Keith Alcorn / 10 January 2019 Viral hepatitis leads to around 1.3 million deaths a year, approximately 257 million people are living with hepatitis B virus (HBV) and 71 million with hepatitis C virus (HCV). Viral hepatitis ... US approves new hepatitis B vaccine as public health agencies update guidelines Liz Highleyman / 27 November 2017 On 9 November the US Food and Drug Administration (FDA) approved Heplisav-B, a new vaccine that provides protection against all known subtypes of hepatitis B virus (HBV) with two rather ... Children on immunosuppressive therapy may lose hepatitis B vaccine protection Liz Highleyman / 22 May 2017 More than half of children treated with immunosuppressive drugs for gastrointestinal or rheumatological conditions no longer had protective levels of antibodies against hepatitis B virus (HBV) and may require repeat vaccination, according to ... Survey shows more than 800,000 people in US have hepatitis B, half of them Asian Liz Highleyman / 23 February 2016 Although nearly 70 million people in the US have been vaccinated against hepatitis B virus (HBV), there are still 847,000 people with evidence of infection, about 400,000 of whom are Asian, according ... Expanded vaccination and treatment could help eliminate hepatitis B worldwide Liz Highleyman / 28 April 2015 While universal infant hepatitis B virus (HBV) vaccination has already led to major advances in reducing new infections in some settings, further expansion of prevention and treatment are needed to significantly reduce HBV ... Hepatitis B vaccine protection lasts for at least 30 years Liz Highleyman / 21 November 2013 Hepatitis B vaccination provides long-term protection through 30 years for a majority of recipients, and more than 90% were protected with either initial immunisation or a booster, according to a presentation at ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive